Literature DB >> 19221431

Cryptic peptides of the kringle domains preferentially bind to disease-associated prion protein.

Kristen Hatcher1, Jian Zheng, Shu G Chen.   

Abstract

Prion diseases are a group of fatal neurodegenerative disorders characterized by the accumulation of a misfolded form (PrP(Sc)) of the cellular prion protein (PrP(C)) in the brains of affected individuals. The conversion of PrP(C) to PrP(Sc) is thought to involve a change in protein conformation from a normal, primarily alpha-helical structure into a beta-sheet conformer. Few proteins have been identified that differentially interact with the two forms of PrP. It has been reported that plasminogen binds to PrP(Sc) from a variety of prion phenotypes. We have examined potential motifs within the kringle region that may be responsible for binding to PrP. We synthesized 12-15-mer peptides that contain small, repetitive stretches of amino acid residues found within the kringle domains of plasminogen. These synthetic peptides were found to capture PrP(Sc) from the brain homogenates of bovine spongiform encephalopathy affected cattle, chronic wasting disease affected elk, experimental scrapie of hamsters and that of subjects affected by Creutzfeldt-Jakob disease, without binding to PrP(C) in unaffected controls. Therefore, we have identified critical peptide motifs that may be important for protein-protein interactions in prion disease pathogenesis. The ability of these synthetic peptides to bind preferentially to PrP(Sc) suggests a potential application in the diagnosis of prion diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19221431      PMCID: PMC2741132          DOI: 10.3233/JAD-2009-0980

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  45 in total

1.  Binding of disease-associated prion protein to plasminogen.

Authors:  M B Fischer; C Roeckl; P Parizek; H P Schwarz; A Aguzzi
Journal:  Nature       Date:  2000-11-23       Impact factor: 49.962

2.  Plasminogen binds to disease-associated prion protein of multiple species.

Authors:  M Maissen; C Roeckl; M Glatzel; W Goldmann; A Aguzzi
Journal:  Lancet       Date:  2001-06-23       Impact factor: 79.321

3.  The binding of prion proteins to serum components is affected by detergent extraction conditions.

Authors:  Yuval Shaked; Roni Engelstein; Ruth Gabizon
Journal:  J Neurochem       Date:  2002-07       Impact factor: 5.372

4.  Plasminogen activation is stimulated by prion protein and regulated in a copper-dependent manner.

Authors:  Vincent Ellis; Maki Daniels; Rashmi Misra; David R Brown
Journal:  Biochemistry       Date:  2002-06-04       Impact factor: 3.162

5.  Cortical neurons of Creutzfeldt-Jakob disease patients express the urokinase-type plasminogen activator receptor.

Authors:  M H Deininger; K Trautmann; V Magdolen; T Luther; H J Schluesener; R Meyermann
Journal:  Neurosci Lett       Date:  2002-05-10       Impact factor: 3.046

6.  Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains.

Authors:  M D Ledesma; J S Da Silva; K Crassaerts; A Delacourte; B De Strooper; C G Dotti
Journal:  EMBO Rep       Date:  2000-12       Impact factor: 8.807

7.  Quantitative traits of prion strains are enciphered in the conformation of the prion protein.

Authors:  J Safar; F E Cohen; S B Prusiner
Journal:  Arch Virol Suppl       Date:  2000

8.  Genetic influence on the structural variations of the abnormal prion protein.

Authors:  P Parchi; W Zou; W Wang; P Brown; S Capellari; B Ghetti; N Kopp; W J Schulz-Schaeffer; H A Kretzschmar; M W Head; J W Ironside; P Gambetti; S G Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

9.  Copper(II) binding modes in the prion octapeptide PHGGGWGQ: a spectroscopic and voltammetric study.

Authors:  R P Bonomo; G Imperllizzeri; G Pappalardo; E Rizzarelli; G Tabbì
Journal:  Chemistry       Date:  2000-11-17       Impact factor: 5.236

10.  Detection of misfolded prion protein in blood with conformationally sensitive peptides.

Authors:  Tao Pan; Jasmeet Sethi; Craig Nelsen; Alan Rudolph; Larisa Cervenakova; Paul Brown; Cindy S Orser
Journal:  Transfusion       Date:  2007-08       Impact factor: 3.157

View more
  3 in total

1.  Plasminogen: A cellular protein cofactor for PrPSc propagation.

Authors:  Charles E Mays; Chongsuk Ryou
Journal:  Prion       Date:  2011-01-01       Impact factor: 3.931

2.  A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo.

Authors:  Yi Xu; Hui Zhao; Ying Zheng; Qing Gu; Jianxing Ma; Xun Xu
Journal:  Mol Vis       Date:  2010-10-07       Impact factor: 2.367

3.  Endoproteolysis of cellular prion protein by plasmin hinders propagation of prions.

Authors:  Charles E Mays; Trang H T Trinh; Glenn Telling; Hae-Eun Kang; Chongsuk Ryou
Journal:  Front Mol Neurosci       Date:  2022-09-02       Impact factor: 6.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.